Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the role of inflammation and the insulin regulating hormone GLP-1 during critical illness.


Clinical Trial Description

Critically ill patients often exhibit hyperglycaemia. Although the cause of this hyperglycaemia is probably multifactorial, peripheral insulin resistance is a major contributor, similar to type 2 diabetes mellitus (T2D). There are several similarities between critical illness and T2D, including the presence of systemic inflammation and increased plasma free fatty acids (FFA), all of which may induce insulin resistance in healthy volunteers. In critical illness, elevated catecholamines, cortisol, growth hormone and glucagon may also contribute to insulin resistance.

The degree of hyperglycaemia correlates with mortality in ICU patients. van den Berghe et al. found that IV infusion of insulin to obtain strict normoglycaemia reduced mortality as well as morbidity in critically ill surgical patients and in some medical ICU patients.

However, insulin increases the risk of hypoglycaemia; this is a major obstacle to strict euglycaemia in ICU patients and may explain the inability of others to reproduce the benefits reported by van den Berghe et al. Thus, alternatives to insulin for controlling plasma glucose (PG) in ICU patients are warranted.

Aim:

To study the role of the incretin hormone, glucagon-like peptide (GLP)-1 for glycaemic, metabolic, hormonal and inflammatory profile in

- critically ill patients in the intensive care unit (ICU) and

- healthy volunteers exposed to a standardised systemic inflammation ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01347801
Study type Interventional
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase N/A
Start date March 2011
Completion date September 2014

See also
  Status Clinical Trial Phase
Completed NCT01922817 - DPP4inhibitors in Type 1 Diabetes Phase 3
Completed NCT02107326 - Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes N/A
Completed NCT01337362 - Recurrent Hypoglycaemia in Type 1 Diabetes N/A
Completed NCT02341313 - Point of Care Ketone Measurement in the Newborn
Completed NCT05470842 - How Common is Hypoglycaemia in Older People With Diabetes Who Fall? N/A
Completed NCT02778269 - Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study N/A
Active, not recruiting NCT02241317 - Diabetes Mellitus at the University Medical Center of Mannheim N/A
Completed NCT02057848 - Carbohydrates to Prevent Hypoglycaemia During Physical Activity in Patients With Type 1 Diabetes N/A
Terminated NCT02836353 - Metabolic Consequences of Gastrointestinal Surgery N/A
Completed NCT01526044 - Continuous Glucose Monitoring by Subcutaneous Measurement Compared to Frequent Point of Care Measurement by Accu Chek in Critically Ill Patients N/A
Completed NCT02347553 - Effect of Hypoglycaemia on Social Cognition and Cardiac Conduction N/A